Evidence map›Paper›PMID 41282797›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Knowledge, perceptions and acceptance of COVID-19 Vaccine in Plateau States, Nigeria: A Qualitative Study.

Sophia Osawe, Sussan Israel-Isah, Timothy Adejoh, Tunde A Alabi, Felicia Okolo, Sikiratu Babamale, Adam Abdullahi, Alash'le Abimiku

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sophia OsaweInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.ORCID 0000-0003-1986-3976
Sussan Israel-IsahInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.ORCID 0009-0002-7886-2850
Timothy AdejohInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.
Tunde A AlabiDepartment of Sociology, University of Lagos, Nigeria.ORCID 0000-0003-4263-1233
Felicia OkoloInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.ORCID 0000-0002-7957-8053
Sikiratu BabamaleInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.ORCID 0000-0001-9733-9112
Adam AbdullahiInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.ORCID 0000-0001-9703-8264
Alash'le AbimikuInternational Research Centre of Excellence, Institute of Human Virology Nigeria (IHVN) Nigeria.

Funding

IMPROVING COVID-19 VACCINATION UPTAKE IN HIV POSITIVE PREGNANT WOMEN IN NIGERIAU01HD094658 · NICHD · INSTITUTE OF HUMAN VIROLOGY · PI ABIMIKU, ALASH'LE G. · 2017 to 2022
$1.5M
NICHD NIH HHS U01 HD094658
6 · The paper itself

Abstract

Introduction and Objectives: Knowledge, perceptions, and acceptance of vaccines play a role in evaluating the progress of past immunization programs and planning for future pandemics. The study assessed the knowledge, perceptions, and acceptance of COVID-19 vaccines among pregnant women, HCWs, and policymakers in Nigeria and identified the barriers and enablers to the uptake of COVID-19 vaccines and future ones. Methods: The study adopted qualitative methods of qualitative collection, comprising focus group discussion (FGD) with pregnant women- who were HIV positive and negative- and key informant interviews (KII) with healthcare workers (HCWs) and policymakers in Plateau State, Nigeria. The sample comprised forty pregnant women, five HCWs and five policymakers. Data was managed using Dedoose (version 9.0) and analyzed thematically. Results: Although all sub-groups acknowledged the importance of vaccination, COVID-19 vaccine hesitancy was identified amongst a significant proportion of pregnant women. This was because of safety concerns, misinformation and fear of side effects. HCWs were identified as key influencers of vaccine acceptance during pregnancy. Also, family and friends, personal beliefs, and awareness were found to be influencers of vaccination, while religious and cultural beliefs were identified as barriers. Policymakers and HCWs believe that there is a need for education and awareness to address misinformation and improve the trust in vaccine safety and the health system among pregnant women. Conclusion: The participants were knowledgeable of vaccines. However, pregnant women expressed skepticism about the safety of the COVID-19 vaccines. Thus, addressing misinformation through public health awareness programs is important while leveraging the influence of the health workforce, community, and religious leaders in promoting vaccine acceptance.

Indexed as

Healthcare workersPolicymakersPregnant womenVaccine acceptanceVaccine hesitancy

Identifiers

PMID41282797
PMCPMC12633102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.